CPC A61F 9/0017 (2013.01) [A61F 2/1637 (2013.01); A61K 31/46 (2013.01); G02B 21/08 (2013.01); G02C 7/021 (2013.01); G02C 7/022 (2013.01); G02C 7/027 (2013.01); G02C 7/04 (2013.01); A61K 9/0051 (2013.01)] | 20 Claims |
1. An ophthalmic lens for use in conjunction with a pharmaceutical agent for an eye with myopia, the ophthalmic lens comprising:
a base lens with a front surface and a back surface;
at least one first viewing region having a first power profile, wherein the size of the at least one first viewing region is configured based, at least in part, on the concentration of the pharmaceutical agent; and
one or more myopia control elements with a power profile different than the first power profile, wherein the myopia control elements are shaped as a circular element, ring, annular ring, partial annular ring, arc shaped element, triangular, or spiral or a combination thereof.
|